S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Biden’s $374B Giveaway Into This Sector (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
1970’s computer coder issues shocking A.I. warning (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
The #1 Crypto for 2024 (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Biden’s $374B Giveaway Into This Sector (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
1970’s computer coder issues shocking A.I. warning (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
The #1 Crypto for 2024 (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Biden’s $374B Giveaway Into This Sector (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
1970’s computer coder issues shocking A.I. warning (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
The #1 Crypto for 2024 (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Biden’s $374B Giveaway Into This Sector (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
1970’s computer coder issues shocking A.I. warning (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
The #1 Crypto for 2024 (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
Free Trial
OTCMKTS:MEDIF

MediPharm Labs (MEDIF) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)
Free MEDIF Stock Alerts
$0.06
0.00 (0.00%)
(As of 04/18/2024 ET)
Compare
Today's Range
$0.05
▼
$0.06
50-Day Range
$0.05
▼
$0.07
52-Week Range
$0.04
▼
$0.08
Volume
48,707 shs
Average Volume
109,989 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartHeadlinesShort Interest
MEDIF stock logo

About MediPharm Labs Stock (OTCMKTS:MEDIF)

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. It also provides GMP flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll products. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.

MEDIF Stock Price History

MEDIF Stock News Headlines

April 17, 2024 | finance.yahoo.com
MediPharm Labs Corp. (MEDIF)
March 29, 2024 | seekingalpha.com
MediPharm Labs Corp. (MEDIF) Q4 2023 Earnings Call Transcript
April 19, 2024 | InvestorPlace (Ad)
New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
March 27, 2024 | investorplace.com
MEDIF Stock Earnings: MediPharm Labs Reported Results for Q4 2023
March 27, 2024 | prnewswire.com
MediPharm Labs Provides Conference Call Recording Details
March 27, 2024 | prnewswire.com
MediPharm Labs Reports Fourth Quarter and Full Year Results
March 25, 2024 | prnewswire.com
MediPharm Labs Provides Update on German Cannabis Legalization
February 7, 2024 | finanznachrichten.de
MediPharm Labs Inc.: MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority
April 19, 2024 | InvestorPlace (Ad)
New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
February 7, 2024 | finance.yahoo.com
MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority
November 14, 2023 | benzinga.com
MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report
November 14, 2023 | msn.com
MediPharm Labs reports Q3 results
October 25, 2023 | finance.yahoo.com
MediPharm Labs Corp (MLZ.BE)
October 25, 2023 | finance.yahoo.com
MediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to Cash
September 20, 2023 | benzinga.com
MediPharm Labs Breaks Free From Royalty Agreement, What It Means & What's Next
August 31, 2023 | finance.yahoo.com
MediPharm Labs Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia Patients
August 14, 2023 | benzinga.com
Cannabinoid-Focused Pharma Stock Slides On Q2 Earnings Report, Here Are The Details
August 14, 2023 | finanznachrichten.de
MediPharm Labs Corp.: MediPharm Labs Reports Second Quarter Results with Doubling of Revenue and Record Margin Growth
August 10, 2023 | finance.yahoo.com
MediPharm Labs Sets Date to Report Second Quarter 2023 Financial Results
August 1, 2023 | benzinga.com
MediPharm Delivers Cannabis Clinical Trial Material To US Research Partner And Provides Update On FDA Status
August 1, 2023 | finance.yahoo.com
MediPharm Labs Makes First Delivery of Cannabis Clinical Trial Material to US Research Partner and Provides Update on US FDA Status
June 26, 2023 | msn.com
Two Pot Companies Continue To Focus On Cannabinoid-Based Self-Emulsifying Drug Delivery Systems
June 22, 2023 | finance.yahoo.com
MediPharm Labs Announces Change of Auditor
June 9, 2023 | fool.com
MediPharm Labs (OTC: MEDIF)
May 10, 2023 | finance.yahoo.com
MediPharm Labs Sets Date to Report First Quarter 2023 Financial Results
May 6, 2023 | theglobeandmail.com
Closing Bell: Medipharm Labs Corp flat on Friday (LABS)
April 25, 2023 | theglobeandmail.com
Closing Bell: Medipharm Labs Corp flat on Tuesday (LABS)
See More Headlines
Receive MEDIF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MediPharm Labs and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:MEDIF
CUSIP
N/A
CIK
N/A
Web
www.medipharmlabs.com
Phone
(705) 719-7425
Fax
N/A
Employees
130
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. David A. Pidduck
    CEO & Director
  • Mr. Keith Strachan
    Co-Founder & President
  • Mr. Greg Hunter
    Chief Financial Officer
  • Mr. Patrick McCutcheon
    Founder
  • Mr. Saravan Subramaniam
    Vice President of Operations & Supply Chain
  • Mr. Geoffrey Marr
    Executive VP & General Counsel
  • Mr. Brett Moon
    Vice President of Sales
  • Mr. Kirk Binns
    Executive Vice President of Global Accounts

Key Competitors

View All Competitors

MEDIF Stock Analysis - Frequently Asked Questions

How have MEDIF shares performed in 2024?

MediPharm Labs' stock was trading at $0.0486 at the beginning of 2024. Since then, MEDIF shares have increased by 17.3% and is now trading at $0.0570.
View the best growth stocks for 2024 here.

How do I buy shares of MediPharm Labs?

Shares of MEDIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MEDIF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Urgent alert: open this for a huge profit potential
Timothy Sykes
The #1 Crypto for 2024
InvestorPlace
How Biden has already won 2024
Porter & Company